Wockhardt today announced that it has received permission from the Central Drugs Standard Control Organization (CDSCO) to export up to 80 million doses of Sputnik Light and up to 20 million doses of Sputnik V Component I vaccine.

Wockhardt’s Bulk vaccine and Fill-Finish manufacturing facilities at Waluj and Shendra, Aurangabad respectively were jointly inspected and approved by Drug inspectors from CDSCO (West zone) & Aurangabad State FDA and Expert from CDL Kasauli to receive export NOC.

The company’s state-of-the-art automated manufacturing facilities in Aurangabad are dedicated to produce world class high quality injectable products. It has entered into an agreement with Russian Direct Investment Fund and Enso Healthcare to manufacture and supply Sputnik V and Sputnik Light vaccines against COVID-19 based on the technology transfer from Gamaleya National Research Institute of Epidemiology and Microbiology.

In the morning trades, the stock reacted very strongly; from its close of Rs.388.05, it opened higher at Rs.402.25 and went up to an intraday high at Rs.408.10 and it is now trading at Rs.394 levels.